Daily Anesthesiology Research Analysis
Analyzed 49 papers and selected 3 impactful papers.
Summary
The strongest studies addressed time-sensitive perioperative systems, opioid-sparing postoperative analgesia, and hemodynamic prevention during spinal anesthesia. A large matched-cohort study linked capacity-related delay in hip-fracture surgery to increased mortality, while two randomized trials supported oliceridine as non-inferior to sufentanil and a lower norepinephrine infusion dose as non-inferior for maintaining blood pressure in elderly patients.
Research Themes
- Capacity-related delay and mortality after hip-fracture surgery
- Opioid-sparing postoperative analgesia in the anesthesia intensive care unit
- Norepinephrine dosing to prevent spinal-induced hypotension in elderly surgical patients
Selected Articles
1. Effects of Capacity-Related Delay to Hip Fracture Surgery on Mortality: A Matched-Cohort Study.
In 2,358 older adults undergoing operative hip-fracture treatment, 54% experienced surgery delayed beyond 36 hours because of operative-capacity constraints rather than medical optimization. After propensity-score matching, capacity-related delay was associated with higher 365-day mortality (HR 1.37, 95% CI 1.15-1.63), with the greatest early effect within 30 days (HR 1.71, 95% CI 1.11-2.65); frailer patients were particularly vulnerable.
Impact: This study isolates a modifiable health-system exposure from medical confounding and quantifies its association with both early and long-term mortality. The findings directly support prioritizing timely hip-fracture surgery, especially for frail older adults.
Clinical Implications: Hospitals should monitor capacity-related surgical delays separately from delays for medical optimization and consider expedited operating-room access for frail patients with hip fractures. The study supports system-level quality-improvement interventions, although it does not prove that reducing delay alone will lower mortality.
Key Findings
- Among 2,358 eligible patients, 46% received timely surgery and 54% experienced capacity-related delay.
- After propensity-score matching, capacity-related delay was associated with higher 365-day mortality (HR 1.37, 95% CI 1.15-1.63).
- The mortality effect was strongest during the first 30 days, and patients with Clinical Frailty Scale scores above 4 were most affected.
Methodological Strengths
- The analysis explicitly excluded delays caused by medical reasons, addressing a major confounder in prior observational studies.
- A large cohort, 96.9% availability of 365-day mortality status, multivariable modeling, and propensity-score matching strengthened the prognostic analysis.
Limitations
- The retrospective single-hospital design limits generalizability and cannot establish causality.
- Residual confounding, including unmeasured system and patient factors, may remain despite matching.
Future Directions: Prospective multicenter studies should evaluate whether reducing capacity-related delay through dedicated trauma pathways, protected operating-room capacity, or regional coordination improves mortality and functional recovery, with particular attention to frailty-stratified effects.
BACKGROUND: Timely surgery is emphasized in hip fracture care. Prior studies examining this have failed to distinguish adequately between delays for medical optimization and those due to limited operative capacity, introducing important confounders. This study aimed to determine the impact of capacity-related delays on mortality after a hip fracture in older individuals, as well as the factors moderating these effects. METHODS: This retrospective cohort study involved patients treated in a U.K. teaching hospital from January 2020 to June 2024. Primary outcomes were mortality at 30 and 365 days. The exposure of interest was capacity-delayed hip fracture surgery, defined as operative anesthesia for hip fracture surgery occurring >36 hours after emergency department presentation.
2. Oliceridine versus Sufentanil for Postoperative Intravenous Analgesia in Patients Undergoing Abdominal Surgery in the AICU: A Double-Blind Non-Inferiority Trial.
In this double-blind randomized non-inferiority trial of 184 patients after abdominal surgery, oliceridine produced non-inferior pain control to sufentanil at 6 hours after extubation. The primary pain difference remained within the prespecified non-inferiority margin, while postoperative nausea was less frequent with oliceridine and other measured recovery outcomes were similar.
Impact: The study provides randomized evidence for an alternative postoperative opioid in a high-acuity anesthesia setting, combining non-inferior analgesia with a potentially more favorable nausea profile. This may inform opioid selection where postoperative recovery and tolerability are priorities.
Clinical Implications: Oliceridine may be considered as an alternative to sufentanil for patient-controlled intravenous analgesia after abdominal surgery, particularly when postoperative nausea is a concern. Dose equivalence, cost, respiratory safety, and generalizability to non-AICU populations require further confirmation.
Key Findings
- The trial randomized 184 postoperative abdominal-surgery patients to sufentanil or oliceridine.
- The 6-hour post-extubation NRS pain score with oliceridine was non-inferior to sufentanil (1.63 ± 0.60 vs 1.75 ± 0.58; upper 95% CI limit 0.06, margin 0.6).
- Oliceridine was associated with a lower incidence of postoperative nausea, while resting pain, sedation, extubation timing, hemodynamics, and pump use did not differ significantly.
Methodological Strengths
- Double-blind randomized non-inferiority design with a prespecified primary outcome and non-inferiority margin.
- Assessment included analgesic efficacy, sedation, extubation-related outcomes, hemodynamics, pump use, and adverse reactions.
Limitations
- The abstract does not establish long-term outcomes, chronic postsurgical pain, or respiratory safety beyond the immediate postoperative period.
- The single clinical setting and selected abdominal-surgery population may limit generalizability to other operations and institutions.
Future Directions: Larger pragmatic trials should compare equianalgesic dosing, respiratory depression, ileus, mobilization, patient satisfaction, cost-effectiveness, and longer-term recovery across diverse surgical populations.
OBJECTIVE: To compare the efficacy of Oliceridine and sufentanil in postoperative pain management, adverse reactions, and their effects on extubation in patients undergoing abdominal surgery in an anaesthesia intensive care unit (AICU). METHODS: This study was a randomised controlled non-inferiority clinical trial conducted between November 2024 and October 2025. It enrolled 184 patients transferred to the AICU following abdominal surgery, who were randomly assigned to Group S (100 μg sufentanil) or Group O (20 mg Oliceridine). In both groups, the analgesic pumps were diluted with normal saline to 100 mL, and patient-controlled intravenous analgesia (PCIA) was administered following transfer to the AICU; the primary outcome was the NRS score 6 hours after extubation.
3. Norepinephrine infusion for prophylaxis against spinal-induced hypotension in elderly patients undergoing hip surgery: a randomized controlled comparison of two doses.
This randomized non-inferiority trial analyzed 84 elderly patients undergoing hip surgery under spinal anesthesia. Norepinephrine at 0.07 mcg/kg/min maintained average intraoperative mean arterial pressure non-inferiorly compared with 0.1 mcg/kg/min, with comparable rates of hypotension, hypertension, and bradycardia.
Impact: The study challenges the assumption that the higher prophylactic norepinephrine rate is necessary in elderly patients and identifies a lower dose that achieved comparable blood-pressure control. Dose reduction could potentially reduce vasopressor exposure while preserving hemodynamic stability, although larger trials are needed.
Clinical Implications: A prophylactic norepinephrine infusion of 0.07 mcg/kg/min may be a reasonable starting strategy for selected elderly patients receiving spinal anesthesia for hip surgery. Individual titration and monitoring remain essential because the trial was small and may not detect uncommon adverse effects.
Key Findings
- Eighty-four elderly patients were analyzed in a randomized non-inferiority comparison of 0.1 versus 0.07 mcg/kg/min norepinephrine.
- Average intraoperative MAP was 87.9 ± 9.5 mmHg with 0.1 mcg/kg/min and 84.5 ± 8.5 mmHg with 0.07 mcg/kg/min; the mean difference was -3.5 mmHg with a 95% CI of -7.4 to 0.4 mmHg.
- The lower dose was non-inferior, and hypotension, hypertension, and bradycardia occurred at comparable rates.
Methodological Strengths
- Randomized non-inferiority design with an explicit 8-mmHg margin and frequent hemodynamic measurements every 2 minutes.
- The study was prospectively registered on ClinicalTrials.gov under identifier NCT07077265.
Limitations
- The analyzed sample was small, with 84 patients, limiting precision and the ability to identify uncommon adverse events.
- The findings apply primarily to elderly patients undergoing hip surgery under spinal anesthesia and may not generalize to other procedures or risk groups.
Future Directions: Multicenter trials should assess patient-centered outcomes, cumulative vasopressor dose, postoperative organ injury, myocardial complications, and optimal titration algorithms across different elderly surgical populations.
BACKGROUND: We aimed to compare the hemodynamic response to two norepinephrine infusion rates for prophylaxis against post-spinal hypotension in elderly population undergoing hip surgery. METHODS: This randomized non-inferiority clinical trial included elderly patients scheduled for hip surgery under spinal anesthesia. Patients received norepinephrine infusion at a rate of 0.1 mcg/kg/min (0.1-mcg group) or 0.07 mcg/kg/min (0.07-mcg group) after spinal anesthesia. Intraoperative mean arterial pressure (MAP) and heart rate were recorded every 2 min for 46 min after spinal anesthesia. The primary outcome was the noninferiority comparison between the two groups regarding the average MAP readings. Non-inferiority was declared if the average post-spinal MAP in the 0.07-mcg group was within 8 mmHg of the 0.1-mcg group.